BUY Vijaya Diagnostic Centre — MarketSmith India, 12 Aug 2026

BUYVijaya Diagnostic Centre Limited

byMarketSmith IndiaHorizon: 1–3 months12 Aug 2026via LiveMint Buy-or-Sell (topic)

Entry₹1,424.5Stated

Target₹1,650

Total upside +15.83%

Stop loss₹1,330-6.63% risk

CMP₹1,493.22d ago

Active+4.82%+10.50%upside left 2 mo left

Follow MarketSmith India for new calls(30% target hit, 10 closed calls)Get alerts Watch VIJAYA for new buy/sell callsGet alerts

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 7 Sept, 3:26 am IST

5 supporting3 neutral3 opposing

Supports the BUY call (5)

Past month's volume 1.3× the prior month's average

Technicals · volume·4 Sept · 2d ago

2 advisors have active long-term BUY calls on this stock, with 1 issued in the last 14 days

Advisor consensus · adjacent horizon·1 Sept · 5d ago

Vijaya Diagnostic Centre sets AGM for Sep 24, proposes ₹2 dividend

NewsGoogle News·26 Aug · 2w ago

Vijaya Diagnostic Centre declares ₹2 dividend; expands ESOP pool

NewsGoogle News·26 Aug · 2w ago

Vijaya Diagnostic Centre: FY26 Revenue Crosses ₹8,142 Million

NewsGoogle News·26 Aug · 2w ago

Neutral / worth noting (3)

Vijaya Diagnostic Centre files FY26 BRSR report with exchanges

NewsGoogle News·26 Aug · 2w ago

Vijaya Diagnostic Centre: AGM and Dividend Record Dates Announced

NewsGoogle News·26 Aug · 2w ago

Weighs against the BUY call (3)

MACD below its signal line — bearish momentum

Technicals · macd·6 Sept · today

Vijaya Diagnostic Centre: Company Secretary Resigns

NewsGoogle News·26 Aug · 2w ago

1 advisor has an active long-term SELL call on this stock

Advisor consensus · adjacent horizon·5 Nov · 10mo ago

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.